|
FOXJ2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.62900000003174E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.57079999999677E-05 |
| Normal-vs-Stage2 |
1.342550E-03 |
| Normal-vs-Stage3 |
4.25609999998855E-06 |
| Normal-vs-Stage4 |
1.162030E-03 |
| Stage1-vs-Stage2 |
8.457200E-01 |
| Stage1-vs-Stage3 |
4.241200E-01 |
| Stage1-vs-Stage4 |
9.691200E-01 |
| Stage2-vs-Stage3 |
7.215200E-01 |
| Stage2-vs-Stage4 |
8.555600E-01 |
| Stage3-vs-Stage4 |
5.422400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.53880000003581E-06 |
| Normal-vs-AfricanAmerican |
9.243700E-02 |
| Normal-vs-Asian |
3.596000E-03 |
| Caucasian-vs-AfricanAmerican |
2.055000E-01 |
| Caucasian-vs-Asian |
5.522000E-01 |
| AfricanAmerican-vs-Asian |
4.746200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.799700E-04 |
| Normal-vs-Female |
1.23809999996727E-06 |
| Male-vs-Female |
3.155600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.000000E-04 |
| Normal-vs-Age(41-60Yrs) |
1.319500000041E-06 |
| Normal-vs-Age(61-80Yrs) |
3.90850000000498E-05 |
| Normal-vs-Age(81-100Yrs) |
5.665900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.535820E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.334600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.927200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.173200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.475200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.160000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.063500E-02 |
| Classical-VS-Follicular |
1.617430E-04 |
| Classical-VS-Other |
1.419410E-01 |
| Classical-VS-Normal |
6.646900E-04 |
| Tall-VS-Follicular |
4.788000E-01 |
| Tall-VS-Other |
5.317400E-01 |
| Tall-VS-Normal |
3.035200E-04 |
| Follicular-VS-Other |
8.615800E-01 |
| Follicular-VS-Normal |
1.69909999958584E-07 |
| Other-VS-Normal |
9.644900E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.8381999999928E-06 |
| Normal-vs-N1 |
1.241480E-04 |
| N0-vs-N1 |
9.461600E-01 |
|
|
